Home/Filings/4/0001567619-22-008614
4//SEC Filing

Feingold Jay 4

Accession 0001567619-22-008614

CIK 0001782223other

Filed

Apr 14, 8:00 PM ET

Accepted

Apr 15, 7:58 PM ET

Size

5.0 KB

Accession

0001567619-22-008614

Insider Transaction Report

Form 4
Period: 2022-04-14
Feingold Jay
Chief Medical Officer
Transactions
  • Award

    Common Stock

    2022-04-14+115,931466,611 total
Footnotes (2)
  • [F1]Represents restricted stock units ("RSUs") that vest on April 13, 2023, subject to the Reporting Person's continued employment through the vesting date.
  • [F2]The Compensation Committee also approved a grant to the Reporting Person, effective January 3, 2023, of an additional 53,931 RSUs that vest on April 13, 2023, subject to the Reporting Person's continued employment through the grant and vesting dates.

Documents

1 file

Issuer

Pyxis Oncology, Inc.

CIK 0001782223

Entity typeother

Related Parties

1
  • filerCIK 0001885838

Filing Metadata

Form type
4
Filed
Apr 14, 8:00 PM ET
Accepted
Apr 15, 7:58 PM ET
Size
5.0 KB